This is the mail archive of the ecos-bugs@sourceware.org mailing list for the eCos project.


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]
Other format: [Raw text]

Tip Sheet boosts your portfolio


H 0 t _S t 0 c k for attention.

Xact Aid Inc. (XAID)
A bio-medical Company focused on diagnostic testing in the area of 
sexually transmitted diseases (STD's).

Current Price: 0.50
XAID commenced trading on September 23, 2005. The Company was in a 
quiet period until October 20, 2005.
The trading volume has been thin during the quiet period.
Average price range between $.45 with a high of $1.05

Is XAID an Undiscovered Gem that is Positioned to Go Higher? Please 
Review Exactly the h0t press release.

Nov 1, 2005 -- Xact Aid, Inc. (XAID - News) is pleased to announce the 
acquisition of the Patent Pending STD (Sexually Transmitted Disease) 
Test "STD Alert." STD Alert is a urine-based test inside a self-contained 
cup that is specially designed and outfitted to be used to rapidly test 
for sexually transmitted diseases.

The Company is presently initiating tests, with the goal of having STD 
Alert able to detect Chlamydia, which, according to the Center for 
Disease Control (C.D.C.) is one of the most widespread STD in the U.S. If 
approved by the FDA, STD Alert would be the first urine based 
self-contained cup rapid test in the world for Chlamydia.

Xact Aide CEO Robert Pautsch says, "It is our goal to help in the fight 
against Sexually Transmitted Diseases and STD Alert might be a major 
step in mitigating the long-term effects of Chlamydia through early 
detection.


Does it Sound New and Exciting to You?  Watch This One Trade.

About Xact Aid

Xact Aid Inc. is a bio medical firm focusing on life science solutions 
for the sexually transmitted disease marketplace.

Over $3 bi||i0n d0||ars are spent in the diagnosis and treatment of 
STD?s in the United States (U.S.), not including HIV and AIDS diagnosis 
and treatment.  The world market is significantly larger than the U.S., 
especially in India, China, Russia, and Eastern Europe and certain 
developing economies as found in Asia and Africa. 

The Company chose to develop its initial test on Chlamydia because 
Chlamydia in the prevalent STD in the U.S.
STD Alert; a Sexually Transmitted Disease Urine Specimen Cup

STD Alert is a self-contained cup that is specially designed and 
outfitted to be used to rapidly test--at the point of specimen 
collection--for sexually transmitted diseases or their antibodies by way of a urine 
specimen deposited in the cup.

The assaying apparatus provides a ?test kit in a collection cup? for 
collecting and analyzing a urine sample for sexually transmitted diseases 
and/or their antibodies.  


Conclusion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is XAID Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch 
this One Trade on Thursday! Go XAID.

Penny stocks are considered highly speculative and may be unsuitable 
for all but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  This report is for entertainment 
and advertising purposes only and should not be used as investment 
advice.  If you wish to stop future mailings, or if you feel you have been 
wrongfully placed in our membership, send a blank e mail with No Thanks 
in the sub ject to daily_tip40@ yahoo.com


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]